Hyogo, Japan

Hideaki Shima

This inventor holds 1 USPTO granted patent. Top assignee: Mitsubishi Tanabe Pharma Corporation. Active years: 2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hideaki Shima. Retrieved from https://idiyas.com/inventor/hideaki-shima-2f6ny4q0

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2009

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Hideaki Shima

Introduction

Hideaki Shima is a notable inventor based in Hyogo, Japan. He has made significant contributions to the field of biochemistry, particularly in the study of dipeptidyl peptidase IV. His work has implications for drug design and development, showcasing the intersection of science and innovation.

Latest Patents

Hideaki Shima holds 1 patent related to the three-dimensional structure of dipeptidyl peptidase IV. This patent includes a crystal of dipeptidyl peptidase IV, a three-dimensional structural coordinate of the enzyme, and methods for obtaining these coordinates. Additionally, it outlines a method for identifying the pharmacophore of the effector of dipeptidyl peptidase IV, as well as a program and medium for utilizing the three-dimensional structural coordinate.

Career Highlights

Shima is currently associated with Mitsubishi Tanabe Pharma Corporation, where he continues to advance his research and innovations. His work is pivotal in understanding the structural biology of enzymes, which can lead to the development of new therapeutic agents.

Collaborations

He has collaborated with esteemed colleagues such as Kiyoshi Kyono and Shigeru Sugiyama, contributing to a rich environment of innovation and research.

Conclusion

Hideaki Shima's contributions to the field of biochemistry and his innovative patent work exemplify the importance of research in drug development. His ongoing efforts at Mitsubishi Tanabe Pharma Corporation continue to push the boundaries of scientific understanding and application.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…